Castor offers a modern, self-service clinical research platform, which enables researchers to design studies and integrate data from any source in real-time. Patients can enroll themselves in trials, consent and share their data online or via a mobile app, allowing the industry to seamlessly shift to decentralized clinical trials (DCT).
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/14/21 | $45,000,000 | Series B |
Eight Roads F-Prime Capital Partners INKEF Capital Two Sigma Ventures | undisclosed |
